LONDON (Reuters) - Bayer AG has launched its new anticoagulant pill Xarelto in Britain and Germany, pricing the product on a par with Sanofi-Aventis's Lovenox injection, the company said on Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback